VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BNT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BNTBrookfield Wealth Solutions Ltd.
$42.14$14.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBNTQuarterly Financials

Brookfield Wealth Solutions Ltd. (BNT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Brookfield Wealth Solutions Ltd. (BNT) quarterly income statement — complete revenue, gross profit & net income history

BNT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue1.63B3.1B3.11B2.91B2.42B5.98B2.75B2.92B2.53B2.33B1.53B2B1.2B1.56B1.35B1.28B278M4.99B2.27B89M
Revenue Growth %-32.46%-48.15%13.13%-0.31%-4.39%157.03%79.27%45.46%110.22%49.45%13.8%56.56%332.73%-68.77%-40.67%1338.2%563.33%1395.93%--
Medical Costs & Claims645.93M1.58B1.97B1.89B2.33B4.63B2.37B2.39B2.01B01.39B000000000
Medical Cost Ratio %39.55%51.05%63.32%65.18%96.44%77.38%86.04%81.92%79.6%0%90.35%0%0%0%0%0%0%0%0%0%
Gross Profit987.13M1.52B1.14B1.01B86M1.35B384M527M516M2.33B148M2B1.2B1.56B1.35B1.28B278M4.99B2.27B89M
Gross Margin %60.45%48.95%36.68%34.82%3.56%22.62%13.96%18.08%20.4%100%9.65%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %1047.83%12.19%197.14%92.03%-83.33%-41.86%159.46%-73.7%-57.11%49.45%-89.02%56.56%332.73%-68.77%-40.67%1338.2%563.33%1395.93%--
Operating Expenses1.62B1.55B384M405M455M428M429M556M154M1.85B81M1.63B1.31B1.4B1.18B1.26B117M5.03B2.28B86M
OpEx / Revenue %99.21%49.87%12.34%13.94%18.82%7.16%15.6%19.07%6.09%79.46%5.28%81.39%108.65%90.04%87.24%98.28%42.09%100.8%100.35%96.63%
Depreciation & Amortization0046.96M43M64M50M63M57M36M22M11M32M-15M-2M12M03M000
Combined Ratio %138.77%100.92%75.67%79.11%115.26%84.53%101.64%100.99%85.69%79.46%95.63%81.39%108.65%90.04%87.24%98.28%42.09%100.8%100.35%96.63%
Operating Income-633.11M-28.43M757M607M-369M925M-45M-29M362M478M67M373M-104M155M172M22M161M-40M-8M3M
Operating Margin %-38.77%-0.92%24.33%20.89%-15.26%15.47%-1.64%-0.99%14.31%20.54%4.37%18.61%-8.65%9.96%12.76%1.72%57.91%-0.8%-0.35%3.37%
Operating Income Growth %-71.57%-103.07%1782.22%2193.1%-201.93%93.51%-167.16%-107.77%448.08%208.39%-61.05%1595.45%-164.6%487.5%2250%633.33%3925%-1961.33%--
EBITDA-540.41M85.29M803.96M650M-305M975M18M28M398M500M78M405M-119M153M184M22M164M-40M-8M3M
EBITDA Margin %-33.09%2.75%25.84%22.37%-12.61%16.3%0.65%0.96%15.74%21.49%5.08%20.21%-9.89%9.83%13.65%1.72%58.99%-0.8%-0.35%3.37%
Interest Expense92.7M118.63M112M82M73M96M99M95M72M318M61M216M301M83M151M36M23M000
Non-Operating Income-92.7M-113.72M-112M-82M-73M-96M-99M-95M-72M-318M-61M000000000
Pretax Income-633.11M-28.43M757M607M-369M925M-45M-29M362M478M67M373M-104M155M172M22M161M-40M-8M3M
Pretax Margin %-38.77%-0.92%24.33%20.89%-15.26%15.47%-1.64%-0.99%14.31%20.54%4.37%18.61%-8.65%9.96%12.76%1.72%57.91%-0.8%-0.35%3.37%
Income Tax-39.45M-49.75M149M91M-87M349M-110M-298M25M25M-10M13M-11M15M33M-3M5M3M-2M1M
Effective Tax Rate %6.23%175%19.68%14.99%23.58%37.73%244.44%1027.59%6.91%5.23%-14.93%3.49%10.58%9.68%19.19%-13.64%3.11%-7.5%25%33.33%
Net Income-600.56M8.12M583M501M-326M563M52M264M335M455M76M363M-98M140M135M27M156M-43M-6M2M
Net Margin %-36.78%0.26%18.74%17.24%-13.48%9.41%1.89%9.06%13.25%19.55%4.95%18.11%-8.15%8.99%10.01%2.11%56.12%-0.86%-0.26%2.25%
Net Income Growth %-84.22%-98.56%1021.15%89.77%-197.31%23.74%-31.58%-27.27%441.84%225%-43.7%1244.44%-162.82%425.58%2350%1250%5100%-2774.13%--
EPS (Diluted)-2.250.011.911.76-1.343.610.401.372.303.131.066.47-1.892.873.020.574.53-1.25-0.350.07
EPS Growth %-67.91%-99.63%377.5%28.47%-158.26%15.34%-62.26%-78.83%221.69%9.06%-64.9%1035.09%-141.72%329.6%962.86%693.87%4018.18%-2262.63%--
EPS (Basic)-2.250.011.911.76-1.343.610.161.372.303.131.066.47-1.892.873.020.574.53-1.25-0.350.07
Diluted Shares Outstanding272.69M304.93M304.93M242.51M242.59M150.36M128.64M172.05M145.47M145.47M71.69M51.79M51.79M50.55M34.82M45.72M34.45M34.45M16.93M27.84M